New daily pill shows promise for weight loss in obesity trial
Disease control
Completed
This Phase 2 study tested a once-daily pill called RGT001-075 in 267 adults who are obese or overweight with weight-related health problems like high blood pressure or sleep apnea. The goal was to see if the drug helps with weight loss and is safe. Participants took either the dr…
Phase: PHASE2 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC